We are live on
!
Find out more
MCM
Matarin Capital Management Portfolio holdings
AUM
$409M
Turnover
30.94%
1-Year Est. Return
33.03%
This Fund
S&P 500
This Quarter
Est. Return
+4.21%
1 Year Est. Return
+33.03%
3 Year Est. Return
+73.2%
5 Year Est. Return
+181.88%
10 Year Est. Return
–
AUM
$1.08B
AUM Growth
+$63.8M
(+6.3%)
Cap. Flow
+$34.9M
Cap. Flow
% of AUM
3.23%
Top 10 Holdings %
Top 10 Hldgs %
12.6%
Holding
322
New
38
Increased
152
Reduced
64
Closed
47
Avg Time Held
1.1
years
Top 10 Avg Time Held
0.5
years
Top 20 Avg Time Held
0.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eagle Pharmaceuticals, Inc.
EGRX
|
+$8.46M |
| 2 |
Hawaiian Holdings, Inc.
HA
|
+$8.23M |
| 3 |
LM
Legg Mason, Inc.
LM
|
+$7.93M |
| 4 |
CHSP
Chesapeake Lodging Trust
CHSP
|
+$7.89M |
| 5 |
Coca-Cola Consolidated
COKE
|
+$7.73M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KCG
KCG Holdings, Inc.
KCG
|
+$9.43M |
| 2 |
MGLN
Magellan Health Services, Inc.
MGLN
|
+$8.69M |
| 3 |
ePlus
PLUS
|
+$8.06M |
| 4 |
Murphy USA
MUSA
|
+$7.57M |
| 5 |
Thor Industries
THO
|
+$7.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.53% |
| 2 | Industrials | 15.88% |
| 3 | Technology | 13.74% |
| 4 | Consumer Discretionary | 13.21% |
| 5 | Healthcare | 13.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
AMC Global Media
AMCX
$417M
| $687K | 0.06% |
+12,862
| New | +$719K |
2017 Q2
0 quarters
|
|
202
Central Garden & Pet Co Class A
CENTA
$2.26B
| $677K | 0.06% |
28,183
-241,293
| -90% | -$6.17M |
2015 Q1
9 quarters
|
|
|
AMAG
203
DELISTED
AMAG Pharmaceuticals
AMAG
| $671K | 0.06% |
36,447
+2,034
| +6% | +$40.3K |
2016 Q4
2 quarters
|
|
|
BPFH
204
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $632K | 0.06% |
41,164
+16,506
| +67% | +$256K |
2017 Q1
1 quarter
|
|
|
EXAC
205
DELISTED
Exactech Inc
EXAC
| $629K | 0.06% |
21,118
-1,117
| -5% | -$32.8K |
2015 Q3
7 quarters
|
|
|
MGLN
206
DELISTED
Magellan Health Services, Inc.
MGLN
| $621K | 0.06% |
8,524
-123,693
| -94% | -$8.69M |
2015 Q1
9 quarters
|
|
207
Vanda Pharmaceuticals
VNDA
$247M
| $621K | 0.06% |
38,075
-25,002
| -40% | -$360K |
2017 Q1
1 quarter
|
|
208
Synaptics
SYNA
$4.66B
| $613K | 0.06% |
+11,854
| New | +$647K |
2017 Q2
0 quarters
|
|
|
XENT
209
DELISTED
Intersect ENT, Inc
XENT
| $585K | 0.05% |
20,936
| – | – |
2016 Q4
2 quarters
|
|
210
UNIFI
UFI
$105M
| $585K | 0.05% |
18,984
-43,525
| -70% | -$1.23M |
2015 Q3
7 quarters
|
|
|
CMD
211
DELISTED
Cantel Medical Corporation
CMD
| $577K | 0.05% |
7,408
+2,763
| +59% | +$208K |
2017 Q1
1 quarter
|
|
|
COBZ
212
DELISTED
CoBiz Financial,Inc
COBZ
| $571K | 0.05% |
32,808
+8,998
| +38% | +$148K |
2017 Q1
1 quarter
|
|
213
OFG Bancorp
OFG
$2.22B
| $552K | 0.05% |
55,186
-8,133
| -13% | -$85.4K |
2017 Q1
1 quarter
|
|
214
Materion
MTRN
$5.14B
| $551K | 0.05% |
+14,745
| New | +$521K |
2017 Q2
0 quarters
|
|
215
Waterstone Financial
WSBF
$357M
| $537K | 0.05% |
28,478
-3,059
| -10% | -$57.6K |
2017 Q1
1 quarter
|
|
216
Lear
LEA
$5.92B
| $535K | 0.05% |
3,766
| – | – |
2015 Q1
9 quarters
|
|
217
PC Connection
CNXN
$2.27B
| $527K | 0.05% |
19,475
+912
| +5% | +$25.1K |
2017 Q1
1 quarter
|
|
218
American Public Education
APEI
$909M
| $519K | 0.05% |
21,957
+481
| +2% | +$11K |
2016 Q1
5 quarters
|
|
219
Costco
COST
$439B
| $512K | 0.05% |
+3,202
| New | +$552K |
2017 Q2
0 quarters
|
|
220
DELISTED
Equity Commonwealth
EQC
| $508K | 0.05% |
16,068
-10,790
| -40% | -$341K |
2015 Q3
7 quarters
|
|
221
ANI Pharmaceuticals
ANIP
$1.65B
| $502K | 0.05% |
10,733
-1,350
| -11% | -$65.1K |
2017 Q1
1 quarter
|
|
222
Daktronics
DAKT
$882M
| $502K | 0.05% |
52,106
-5,693
| -10% | -$53.7K |
2017 Q1
1 quarter
|
|
223
Travere Therapeutics
TVTX
$4.67B
| $492K | 0.05% |
25,355
+2,333
| +10% | +$42.3K |
2017 Q1
1 quarter
|
|
224
Huntsman Corp
HUN
$1.49B
| $490K | 0.05% |
18,975
| – | – |
2017 Q1
1 quarter
|
|
225
Cogent Communications
CCOI
$393M
| $488K | 0.05% |
+12,170
| New | +$504K |
2017 Q2
0 quarters
|
|
Similar funds
GBBWRPM
PSSGI
RA
TAM
SIVVM
SM
NFG
AWW
Matarin Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, Matarin Capital Management held 322 positions worth $1.08B, up 6.3% from $1.02B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Matarin Capital Management deployed $34.9M of net new capital in Q2 2017, opening 38 new positions and adding to 152 existing holdings. Its largest new stake was Eagle Pharmaceuticals, Inc.: 103,444 shares worth $8.16M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 19% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Magellan Health Services, Inc., an estimated $8.69M trimmed.
- Matarin Capital Management's largest Q2 2017 buy was Eagle Pharmaceuticals, Inc.: 103,444 shares worth $8.16M.
- Matarin Capital Management added most to Chesapeake Lodging Trust in Q2 2017, an estimated $7.89M increase.
- Matarin Capital Management's biggest Q2 2017 reduction was Magellan Health Services, Inc., cutting an estimated $8.69M.
- Matarin Capital Management fully exited KCG Holdings, Inc. in Q2 2017, selling an estimated $9.43M.
- Matarin Capital Management's ten largest holdings make up 13% of its $1.08B portfolio in Q2 2017.
- Matarin Capital Management opened 38 new positions and closed 47 in Q2 2017.
- Matarin Capital Management's portfolio value rose 6.3% quarter-over-quarter to $1.08B.
Based on Matarin Capital Management's 13F filing for Q2 2017, filed 9 Aug 2017.